Navigation Links
ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications
Date:2/26/2013

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company developing novel therapies for serious or life-threatening diseases with significant unmet needs.  ADVENTRX is leveraging the MAST platform to develop ANX-188, its lead product candidate, for conditions characterized by microcirculatory insufficiency (endothelial dysfunction and/or impaired blood flow).  The Company initially is developing ANX-188 in sickle cell disease and is recruiting subjects in EPIC, a randomized, double-blind, placebo-controlled phase 3 study in patients with sickle cell disease.  More information can be found on the Company's web site at www.adventrx.com.

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding the potential for the MAST platform to facilitate development of ANX-188 in one or more indications, including by reducing time and expense of its development in any particular indication, the potential for the pharmacodynamics properties of ANX-188 to translate into clinical benefit in one or more indications, and the timing of development in ANX-188 in indications outside of sickle cell disease.  Among the factors that could cause or contribute to material differences between ADVENTRX's actual results and expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: the potential for delays in the commencement or completion of clinical studies, including as a result of difficulties in obtaining regulatory agency agreement on clinical development plans or clinical study design, opening trial sites, enrolling study subjects, manuf
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4
2. ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12
3. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
4. ADVENTRX Reports Third Quarter 2012 Financial Results
5. ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188
6. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
7. ADVENTRX Pharmaceuticals To Present At The Rodman & Renshaw Annual Global Investment Conference On September 10
8. ADVENTRX Announces Appointment Of Chief Medical Officer
9. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
10. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
11. ADVENTRX Pharmaceuticals To Present At The OneMedForum New York 2012 Emerging Company Finance Conference On July 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , October 22, 2014 ... ), a clinical-stage pharmaceutical company focused on ... reported positive top-line clinical results from its Phase ... oral insulin capsules, to treat type 1 diabetes. The ... States under a U.S. Food and ...
(Date:10/22/2014)... 2014 Influenza will affect as many as 200,000 ... the United States as high as 49,000 people.  ... is from person to person in respiratory droplets of coughs ... of death, but kills much fewer people each year than ... human fluids including sweat, saliva, blood and other bodily fluids. ...
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, October ... complimentary registration available at: http://bit.ly/1yStiU9 ... Vidyasekar and Visionary Innovation Research Group Senior ... electricity, self-assembling materials, nanobots and flexible electronics ... will transform our lives in the coming ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter TUESDAY, ... diagnosed with Ebola while working for NBC News in ... the special isolation unit at Nebraska Medical Center in Omaha, where ... said Tuesday. A blood test confirmed by the U.S. Centers ... head home to Providence, R.I., NBC News reported Tuesday ...
(Date:10/20/2014)... With a mere 19 days to November 4, ... fundraising stop at the  Law Offices of Dan ... debate last night with his opponent Gov. Rick Scott, ... seven minutes because Crist had an electric fan underneath ... one word: "weird." , Before touching on his well-known ...
(Date:10/20/2014)... 20, 2014 The Advocator Group, ... at the American Foundation for Suicide Prevention’s (AFSP) Out ... is a not-for-profit organization that hosts hundreds of community ... these events are used to help understand and prevent ... personal relationships as well. , The Advocator Group ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, MD, ... Columbus, Inc., A Division of MaternOhio Clinical Associates, Inc., ... 100,000 patients annually. Dr. Murphy will provide a full ... a women’s life. She is accepting new patients at ... Dublin. , Dr. Murphy offers a wide variety of ...
(Date:10/20/2014)... 20, 2014 hc1.com today announced ... cloud solution that enables healthcare organizations of all ... healthcare-specific customer relationship management (“CRM”) solution. , Designed ... needs of the healthcare industry, the hc1 Healthcare ... and patients by combining healthcare CRM, HIPAA-compliant collaboration, ...
Breaking Medicine News(10 mins):Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
... and into woman,s body cavity , , FRIDAY, Aug. 8 ... the first operation of its kind in the United ... removed a woman,s gallbladder without making any external incisions. ... ongoing clinical research trial, involved insertion of an endoscope ...
... Men Living in Senior Housing Growing; Adoption of Healthy Lifestyle ... ... -. In the face of conventional,wisdom, which has long proven true, women ... more men than ever are moving,into senior living residences nationwide. Historically female-dominated,senior ...
... and,Palliative Care Organization and National Hospice Foundation honor ... This prestigious award,celebrates innovation in end-of-life care and ... Award recipients were announced July 25 at ... This year,s Award winners are:, -- Pain ...
... HIV transmission and the degree to which people are able ... words, hope, have been overlooked in policies to tackle HIV/AIDS. ... Council (ESRC) argues that hope is a powerful tool in ... 30 years into the AIDS epidemic a medical vaccine for ...
... Summer ... Internship, ... across southwestern Pennsylvania,and the Pittsburgh region, have taken part in the ... goal of the program is to expose greatly increased numbers of ...
... of victims get to hospital quickly enough to limit damage, ... people who have strokes don,t act quickly enough to get ... study finds. , "One of the problems is that a ... stroke," said Kathryn M. Rose, a research associate professor of ...
Cached Medicine News:Health News:New Technique Removes Gallbladder Without External Incisions 2Health News:More Men Moving Into Senior Residences 2Health News:More Men Moving Into Senior Residences 3Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 2Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 3Health News:Hope: An overlooked tool in the battle against HIV/AIDS 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 3Health News:Many Miss Out on Stroke Treatment 2Health News:Many Miss Out on Stroke Treatment 3
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors....
With a large white surface and a black X in the center, knockout really makes you look the heavyweight....
Icefire has ice crystals on the top of a cool blue iris....
This design features a solid red iris....
Medicine Products: